GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q4 2022
Top Holdings53 positions
CIGNA CORP NEW | 1.8M | $609.6M | 13.5% | $202.92 | +52.01% | 17 qtrssince 2018-Q4 | Decreased 0 |
TENET HEALTHCARE CORP COM NEW | 8.9M | $434M | 9.6% | $27.16 | +79.63% | 17 qtrssince 2018-Q4 | Increased 67 |
State Street Spdr S&p 500 Etf Trust TR UNIT | 718,900 | $274.9M | 6.1% | — | — | — | New — |
DXC TECHNOLOGY CO | 9.7M | $257.2M | 5.7% | $38.73 | -31.58% | 17 qtrssince 2018-Q4 | Increased 60 |
FISERV INC | 2.5M | $255M | 5.7% | $103.02 | -1.89% | 14 qtrssince 2019-Q3 | Decreased 0 |
MCKESSON CORP | 650,643 | $244.1M | 5.4% | $144.46 | +155.90% | 17 qtrssince 2018-Q4 | Decreased 0 |
GLOBAL PMTS INC | 2.4M | $237.5M | 5.3% | $148.26 | -35.62% | 9 qtrssince 2020-Q4 | Increased 66 |
US Foods Holding Corp | 3.8M | $130.8M | 2.9% | $36.34 | -6.39% | 5 qtrssince 2021-Q4 | Decreased 0 |
UNIVERSAL HLTH SVCS INC | 905,748 | $127.6M | 2.8% | $138.92 | 0.00% | 1 qtr | New 78 |
COCA COLA EUROPEAN PARTNERS | 2.1M | $114.5M | 2.5% | $47.04 | +7.98% | 8 qtrssince 2021-Q1 | Increased 52 |
VALVOLINE INC | 3.5M | $114.1M | 2.5% | $28.92 | +12.91% | 4 qtrssince 2022-Q1 | Increased 53 |
HCA HEALTHCARE INC | 439,985 | $105.6M | 2.3% | $151.59 | +54.48% | 17 qtrssince 2018-Q4 | Increased 68 |
BAXTER INTL INC | 2M | $102.4M | 2.3% | $73.70 | -35.87% | 12 qtrssince 2020-Q1 | Decreased 0 |
Uber Technologies Inc | 4M | $99M | 2.2% | $40.30 | -38.63% | 7 qtrssince 2021-Q2 | Decreased 0 |
F M C CORP | 721,996 | $90.1M | 2.0% | $80.30 | +37.92% | 17 qtrssince 2018-Q4 | Decreased 0 |
FLEX LTD | 4.1M | $86.9M | 1.9% | $13.36 | +21.00% | 8 qtrssince 2021-Q1 | Increased 57 |
APTIV PLC | 921,271 | $85.8M | 1.9% | $109.14 | -14.67% | 9 qtrssince 2020-Q4 | Decreased 0 |
CLARIVATE PLC | 10.1M | $84M | 1.9% | $9.89 | -15.70% | 3 qtrssince 2022-Q2 | Increased 76 |
DUPONT DE NEMOURS INC | 1.1M | $78.6M | 1.7% | $80.22 | +0.27% | 9 qtrssince 2020-Q4 | Decreased 0 |
ACTIVISION BLIZZARD INC | 970,273 | $74.3M | 1.6% | — | — | 5 qtrssince 2021-Q4 | Increased 75 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $4.5B across 53 positions as of Q4 2022. Top holdings: CI (13.5%), THC (9.6%), SPY puts (6.1%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 9 new positions, 11 exits, 19 increased. Top move: UHS (NEW, conviction 78). Portfolio: $4.5B across 53 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR